Objective-A high-saturated fatty acid-and cholesterol-containing (HFHC) diet is considered to be a major risk factor for cardiovascular disease. The present study aimed to determine the effects of this Western-type diet on high-density lipoprotein (HDL) metabolism and reverse cholesterol transport (RCT) from macrophages to feces. Methods and Results-Experiments were carried out in mice fed a low-fat, low-cholesterol diet, an HFHC diet, or an HFHC diet without added cholesterol (high-saturated fatty acid and low-cholesterol [HFLC]). The HFHC diet caused a significant increase in plasma cholesterol, HDL cholesterol, and liver cholesterol and enhanced macrophage-derived [ 3 H]cholesterol flux to feces by 3-to 4-fold. These effects were greatly reduced in mice fed the HFLC diet. This HFHC diet-mediated induction of RCT was sex independent and was not associated with obesity or insulin resistance. The HFHC diet caused 1.4-and 3-fold increases in [ 3 H]cholesterol efflux to plasma and HDL-derived [ 3 H]tracer fecal excretion, respectively. Unlike a low-fat, low-cholesterol and HFLC diets, the HFHC diet increased liver ABCG5/G8 expression. The effect of the HFHC diet on fecal macrophage-derived [ 3 H]cholesterol excretion was totally blunted in ABCG5/G8-deficient mice. Conclusion-Despite its deleterious effects on atherosclerosis, the HFHC diet promoted a sustained compensatory macrophage-to-feces RCT. Our data provide direct evidence of the crucial role of dietary cholesterol signaling through liver ABCG5/G8 upregulation in the HFHC diet-mediated induction of macrophage-specific RCT. (Arterioscler Thromb Vasc Biol. 2011;31:2493-2499.)
D ietary saturated fat intake has been associated with an increased risk of atherosclerotic cardiovascular disease and metabolic diseases, such as obesity and type 2 diabetes. 1, 2 This effect is thought to be mediated by an increase in plasma cholesterol, mainly low-density lipoprotein cholesterol. 3 However, both dietary saturated fat and cholesterol intake are known to raise plasma high-density lipoprotein cholesterol (HDL-C) levels. 4 -8 Several epidemiological studies and 1 meta-analysis of 60 controlled trials showed a positive correlation between high saturated fat intake and HDL-C. 9 -11 In an attempt to determine the mechanism underlying this paradoxical observation, several studies reported that a low saturated fat and cholesterol intake reduced HDL-C levels by reducing the apolipoprotein A-I secretion rate. [12] [13] [14] However, other studies found this effect to be associated with decreased apolipoprotein A-I fractional catabolic rates. 15, 16 Also, when dietary cholesterol was increased along with total and saturated fat, increases in large high-density lipoprotein (HDL) subpopulations and HDL apolipoprotein E amounts were observed. 7, 17 Macrophage-specific reverse cholesterol transport (RCT) is thought to be one of the most important HDL-mediated cardioprotective mechanisms. 18 HDL plays a critical role in cholesterol efflux from macrophages, the first step in RCT. 18 However, despite the reported changes in HDL composition and size, the results of several human studies on the effect of dietary fatty acid composition and cholesterol amount on cellular cholesterol efflux to HDL are contradictory. 19 -24 In the present study, we evaluated the effect of a high-saturated fatty acid, Western-type diet, with or without added cholesterol, on the entire macrophage-specific RCT pathway using a validated mouse assay in which radiolabeled cholesterol from macrophages is traced in plasma, liver, and feces. 18, 25 Our results demonstrate that a high-saturated fat and cholesterol-containing diet increased macrophage-to-feces RCT and that dietary cholesterol and liver ABCG5/G8 upregulation played a major role in this paradoxical increase.
Methods
All animal procedures were conducted in accordance with published regulations and reviewed and approved by the Institutional Animal Care Committee of the Institut d'Investigacions Biomèdiques Sant Pau. A detailed description of methods used in the present study is provided in the Supplemental Data, available online at http:// atvb.ahajournals.org. A brief description of the methods is given below.
C57BL/6 and human cholesteryl ester transfer protein (CETP) transgenic mice were obtained from the Jackson Laboratory. ABCG5 and ABCG8 double heterozygous mice were crossed to produce wild-type (ABCG5G8 ϩ/ϩ ) and double knockout ABCG5G8 ( Ϫ/Ϫ ) mice. 26 All mice were maintained on a low-fat, low-cholesterol (LFLC) chow diet containing 3% fat and 0.02% cholesterol. Mice were fed for 8 additional weeks with the LFLC diet, a high-saturated fatty acid-and cholesterol-containing (HFHC) diet containing 21% fat (saturated fat/total fat ratioϭ0.64) and 0.2% cholesterol or the high-saturated fatty acid and low-cholesterol (HFLC) diet. The HFLC diet contained 0.05% cholesterol and was prepared exactly as the HFHC diet was, with the sole difference being a cholesterol supplementation in the latter. A detailed description of dietary fatty acid composition is provided in Supplemental Table I . The methods used for plasma lipid and apolipoprotein analyses have been described in detail elsewhere. [27] [28] [29] For the in vivo macrophage-specific reverse cholesterol method, [ 3 H]cholesterol-labeled mouse macrophages were injected into the peritoneal cavity, and the rate of RCT was measured after 48 hours of macrophage injection. 26, 30 Glucose tolerance tests were performed by intraperitoneal administration of glucose (1 mg/g of body mass) and subsequent measurement of plasma glucose at tϭ0 (baseline) and 20, 60, 120, and 180 minutes. 31 Autologous [ 3 H]cholesteryl oleate-labeled HDL were prepared and injected intravenously into each mouse. 26 Blood was collected into tubes at 1, 3, 6, 24, and 48 hours, and the fractional catabolic rate was determined. 32 At the end of the experiment, fecal [ 3 H]cholesterol and the [ 3 H]tracer detected in fecal bile acids were determined. Liver and small intestine RNA were isolated and polymerase chain reaction assays were performed on an Applied Biosystems Prism 7000 sequence detection system. 26 One-way ANOVA with a Tukey multiple comparison post test was used to compare differences among groups. A probability value Ͻ0.05 was considered statistically significant.
Results

Plasma Lipoproteins, Liver Lipids, and Atherosclerosis
Male C57BL/6 mice fed the HFHC diet for 8 weeks showed several previously reported changes, such as increased mean weight, plasma cholesterol, and HDL-C (Table) . 31, 33 HFLC intake resulted in a significant increase in HDL-C, although this change was less pronounced than that in mice fed an HFHC diet (Table) . High-fat diets did not affect plasma triglyceride levels. We further studied the effects of diets on HDL apolipoprotein amount (Table) . Mice fed both the HFHC and HFLC diets showed a significant increase in apolipoprotein A-I compared with the LFLC diet. Plasma and HDL-associated apolipoprotein E were increased in HFHC diet-fed mice compared with the LFLC and the HFLC groups. Nondenaturing gel gradient electrophoresis revealed that both the HFHC and HFLC diets produced a marginal increase on the size distribution of plasma HDL (Supplemental Figure I ). On the other hand, the HFHC diet did increase liver cholesterol and triglycerides (Table) . This liver cholesterol increase resulted mainly from the increase in cholesteryl esters. The HFLC-induced increase in liver lipids was less pronounced compared with that in HFHC diet-fed mice. Plasma and liver lipid changes were not associated with changes in net intestinal cholesterol absorption (Table) . C57BL/6 mice fed the HFHC diet for 24 weeks developed more early aortic atherosclerosis than LFLC-fed mice (Supplemental Table II ). As previously reported, the atherosclerosis area was greater in females than in males. 34
In Vivo Macrophage-Specific RCT
To ascertain whether saturated fat and cholesterol intake affected macrophage-dependent RCT pathway in vivo, radiolabeled macrophages were injected into male C57BL/6 mice fed either the LFLC, HFHC, or LFLC diet. The [ 3 H]tracer recovery was measured in plasma and HDL at 24 and 48 hours and in liver at 48 hours, and feces were collected over 48 hours. Approximately 80% of radiolabeled [ 3 H]cholesterol was bound to plasma HDL of mice at 24 hours and increased significantly in mice fed the HFHC and HFLC diets (2.8Ϯ0.2 and 3.0Ϯ0.4, respectively, versus 1.7Ϯ0.1% of injected dose in the LFLC group; PՅ0.05). However, plasma, HDL and liver [ 3 H]cholesterol levels at 48 hours were not affected by the fat content of the diet ( Figure 1A and 1B). Thin layer chromatography analyses showed that the HFHC diet caused a significant increase in liver [ 3 H]cholesteryl esters and a pronounced reduction in liver free [ 3 H]cholesterol ( Figure  1B) . Fecal macrophage-derived [ 3 H]tracer excretion in mice given the HFHC diet was significantly higher than in mice given the LFLC and resulted mainly from the increase in radiolabeled [ 3 H]cholesterol ( Figure 1C ). The dietary stimulus on RCT was almost totally absent in mice fed the HFLC diet. The HFHC diet also increased significantly the net fecal [ 3 H]cholesterolϩbile acid excretion in female C57BL/6 mice compared with mice given either the LFLC or HFLC diet (Supplemental Figure IIA) .
Table. Plasma and Liver Lipids in Male C57BL/6 Mice Fed a Low-Fat, Low-Cholesterol (LFLC) Diet, a High-Saturated Fatty Acid-and Cholesterol-Containing (HFHC) Diet, or a High-Saturated Fatty Acid, Low-Cholesterol (HFLC) Diet
Given that CETP plays a crucial role in lipoprotein metabolism in humans, we determined plasma lipoproteins and macrophage RCT in humanized male CETP-transgenic mice fed an LFLC, HFHC, or HFLC diet (Supplemental Table III ). The HFHC and HFLC diets induced a HDLraising effect in these transgenic mice similar to that found in wild-type mice. Also, similar to the findings in wild-type mice, the HFHC diet induced a significant increase in fecal macrophage-derived [ 3 H]tracer excretion in human CETP transgenic mice compared with either an LFLC or HFLC diet.
Given that the HFHC diet induces obesity and insulin resistance in C57BL/6 mice 35 and those have been associated with an impaired ability of HDL to induce cholesterol efflux, 36 we aimed to ascertain whether long-term feeding with the HFHC diet could affect fecal excretion of macrophage-derived [ 3 H]tracer. As expected, the male C57BL/6 mice gained weight rapidly (Figure 2A ). Basal glucose levels and area under the curve of the glucose tolerance test were raised in mice given the HFHC diet for 8, 16, or 24 weeks ( Figure 2C and 2E changes were only found after the 24-week diet period ( Figure 2B , 2D, and 2F). However, the HFHC diet increased net fecal [ 3 H]cholesterolϩbile acid excretion in all experimental groups regardless of the HFHC diet period and obesity or insulin resistance development ( Figure 2G and 2H ).
RCT Step Evaluation: Cholesterol Efflux and HDL Catabolism
Cholesterol efflux from P388D1 macrophage cultures to plasma of male C57BL/6 mice fed the HFHC was 1.4-fold higher than that of mice fed the LFLC or HFLC diet ( Figure  3A ). This variable correlated with HDL-C levels when fit to a linear model (rϭ0.57, Pϭ0.018). Another key step in macrophage-specific RCT is liver HDL-derived cholesterol uptake and biliary secretion. To determine the fate of Figure  3B ). Importantly, recovery of HDL-derived [ 3 H]cholesterol in feces was 3-fold higher in mice fed the HFHC diet, whereas the ability of HFLC diet-fed mice to increase excretion of fecal HDL-derived [ 3 H]cholesterol was completely blunted ( Figure 3C ).
Liver and Small Intestine Gene Expression Analyses
Liver expression of genes involved in HDL synthesis and biliary cholesterol excretion was evaluated. The HFHC diet strongly upregulated ABCG1 and ABCG5 gene expression ( Figure 4A and Supplemental Figure IIB ). Liver ABCG8 expression was found to be significantly upregulated in the groups given the HFHC and HFLC diets ( Figure 4A ). However, the expression of other major HDL synthesisrelated genes, such as apoA-I, ABCA1, and LCAT, was not affected by the diet (Figure 4A ). No significant changes in liver SR-BI and CYP7A1 mRNA expression were found among groups ( Figure 4A ). Small intestine ABCG5 and ABCG8 expression was similar in all groups ( Figure 4B ). However, the HFHC diet downregulated intestinal NPC1L1 and SR-BI expression compared with the LFLC diet.
The Effects of ABCG5/G8 Expression on HFHC-Induced Macrophage-Specific RCT Pathway
To study the in vivo effect of ABCG5 and ABCG8 on RCT, a separate experiment was conducted to determine macrophage-to-feces RCT in wild-type male (ABCG5G8 ϩ/ϩ ) mice and male ABCG5G8 Ϫ/Ϫ mice fed the LFLC, HFHC, or HFLC diet ( Figure 5 ). The amount of [ 3 H]fecal cholesterol was 3.0-fold higher in ABCG5/G8 ϩ/ϩ mice fed the HFHC compared with the LFLC and HFLC groups. The HFHC diet stimulus on RCT was completely blocked in male ABCG5/ G8 Ϫ/Ϫ mice ( Figure 5 ). Similar results were found in females (Supplemental Figure IIC) .
Discussion
Strong evidence supports a HDL-C-raising effect of diets enriched in saturated fat and cholesterol in humans. 4 -11 In the current study, we showed that an HFHC diet promotes macrophage-to-feces RCT in vivo that depends mainly on dietary cholesterol. In contrast, our results indicated that saturated fat intake did not affect macrophage-to-feces RCT. However, the differences in the source of fats and proteins do not permit definitive conclusions to be drawn as to whether LFLC and HFLC could promote differences in macrophageto-feces RCT.
Many studies have attempted to determine whether variations in dietary fat produce changes in cellular cholesterol efflux to plasma. However, dietary saturated fat and cholesterol amount do not appear to affect cholesterol efflux to plasma in most of the studies conducted in humans [22] [23] [24] and animals. 37, 38 Our in vitro cellular cholesterol efflux results were more comparable to those reported by Blanco-Molina et al 20 where the ability of serum to promote cholesterol efflux was slightly greater in 14 human subjects after a low-fat, high-cholesterol diet compared with the low-fat diet alone. Our results are also consistent with the reported HFHC diet-mediated effects on HDL-C and cholesterol efflux from macrophages and liver ABCG1 expression in mice. 39 However, although the HFHC diet exerted a significant stimulatory effect on the transfer of cholesterol from macrophages to feces, cholesterol-derived radioactivity in plasma and liver at 48 hours was similar among groups. This lack of association between [ 3 H]cholesterol levels in plasma and liver and cholesterol mass has been reported previously. 26, 30, 40, 41 It should be noted that RCT is a dynamic process and [ 3 H]cholesterol levels in intermediate compartments at any time point may not reflect the flux of [ 3 H]cholesterol through different compartments. To evaluate additional RCT steps downstream from the cholesterol efflux, we carried out an HDL turnover study by injecting [ 3 H]cholesteryl oleate-labeled HDL. Our studies indicated that the HFHC diet did not affect liver SR-BI expression or plasma HDL clearance. These results are comparable to those previously obtained in mice and hamsters with a similar dietary change. 33, 42 However, the mouse study also found a moderate reduction in HDL fractional catabolic rate. 33 The differences might be attributed, at least in part, to differences in the radiolabeled substrate because those authors used [ 3 H]cholesteryl oleoyl ether-labeled rat HDL.
Nevertheless, despite no changes in plasma HDL clearance, the HFHC diet significantly promoted fecal HDLderived cholesterol excretion in mice. Our results indicate that the major effect of the HFHC diet accelerating the rate of fecal [ 3 H]cholesterol excretion involves liver ABCG5/G8 upregulation. We also found that the HFHC diet upregulated other liver X receptor-regulated genes, such as liver ABCG1 and SREBP-1c (data not shown). 26 Glucose can activate liver X receptor 43 ; however, the HFHC diet-induced effects on RCT were also found in females, with no modifications in plasma glucose levels. Therefore, one possible mechanism contributing to this effect may be related to the increased flux of cholesterol through the liver and, consequently, the increased generation of oxysterols which can activate liver X receptor. 44 Of note, Nishimoto et al 45 reported that a fish oil-and cholesterol-enriched diet significantly promoted macrophageto-feces RCT, which was closely associated with increased liver ABCG5 and ABCG8 expression and reduced liver [ 3 H]cholesteryl esters. However, 2 key points should be taken into account: first, all the diets used in that study contained the same amount of cholesterol (1.25%, higher than in the present study) 45 ; second, omega-3 fatty acids are poor substrates for acyl-coenzyme A:cholesterol acyltransferase, and in addition, liver Scd1 mRNA was found to be decreased. 45 Both decreased enzymatic activities diminish the liver content of cholesteryl esters. 45 Our results rule out the possibility that the HFHC diet differentially inhibited intestinal cholesterol absorption and that this resulted in increased RCT in vivo, as occurred with ezetimibe treatment or specific intestinal liver X receptor activation. 46, 47 Furthermore, even though a Western-type diet increased transintestinal cholesterol export in mice by 50%, 48 this would not explain the substantially higher RCT-raising effect of the HFHC diet, which, in different experiments shown here, was in the range of 3-to 4-fold. Furthermore, transintestinal cholesterol export changes were dependent on the increase in dietary fat content rather than that of cholesterol. 48 We and others 18, 25 recently showed macrophage-specific RCT to be a good predictor of atherosclerosis susceptibility in mouse models of lipoprotein disorders and atherosclerosis. This would not be the case in mice fed an HFHC diet because they showed both increased macrophage-specific RCT and atherosclerosis susceptibility. This suggests that the observed increased macrophage-specific RCT is an insufficient, compensatory mechanism to protect against atherosclerosis development. Therefore, HFHC diet-mediated effects on HDL antiinflammatory activity, 49 non-HDL-C, and fat cells and macrophage inflammation 50 appear to be the major contributor to atherosclerosis in these mice.
A recent report showed that diet-induced dyslipidemia impaired macrophage-to-feces RCT in hamsters fed a low-fat diet containing 0.3% cholesterol, although it did cause a pronounced increase in HDL-C. 51 Hamsters express CETP, but the HFHC diet also promoted RCT in our CETP transgenic mice. The differences in these results may be attributable to the specific diet-induced changes in the liver gene expression profile of hamsters. Thus, the dyslipidemic diet used in hamsters upregulated liver ABCA1 and ABCG5 expression but caused a severe downregulation in liver SR-BI, a known positive regulator of in vivo macrophage-specific RCT. 52 In conclusion, our results demonstrate that an HFHC diet promoted the fecal excretion of macrophage-and HDLderived cholesterol. This RCT increase was independent of other metabolic HFHC diet-induced complications, such as obesity and insulin resistance. The presence of dietary cholesterol and liver ABCG5 and ABCG8 transporters is required for the HFHC-mediated induction of RCT. Because the HFHC diet also promoted atherosclerosis, this change in RCT may constitute a compensatory mechanism to protect macrophages from cholesterol accumulation.
